Der Markt für ferngesteuerte Herzüberwachung wird bis 2028 voraussichtlich 31.671,69 Millionen US-Dollar erreichen, gegenüber 4.976,40 Millionen US-Dollar im Jahr 2021; Es wird geschätzt, dass sie von 2021 bis 2028 mit einer jährlichen Wachstumsrate von 30,3 % wachsen wird.
Geräte zur Fernüberwachung des Herzens ermöglichen eine kontinuierliche Überwachung der elektrischen Aktivitäten des Herzens außerhalb von Krankenhäusern. Sie ermöglichen auch die elektrokardiographische (EKG) Überwachung zu Hause bei Patienten mit Verdacht auf Herzrhythmusstörungen oder einem Risiko für die Entwicklung von Herzrhythmusstörungen. Die Überwachung kann auch durchgeführt werden, wenn Patienten in ihre Alltagsaktivitäten vertieft sind. Einer der wichtigsten Vorteile der Fernüberwachung von Herzgeräten besteht darin, dass die Notwendigkeit routinemäßiger Arztbesuche verringert wird. Geräte wie Herzschrittmacher und implantierbare Kardioverter-Defibrillatoren werden durch minimalinvasive Verfahren in das Herz des Patienten implantiert. Die Übertragung der Daten übernimmt ein Sender, der synchron mit dem Gerät arbeitet. Faktoren wie die zunehmende Inzidenz von Herz-Kreislauf-Erkrankungen (CVDs) und die kontinuierliche Weiterentwicklung des telemedizinischen Ansatzes fördern das Wachstum des Marktes für die Fernüberwachung des Herzens. Bedenken hinsichtlich des Datenschutzes behindern jedoch das Marktwachstum.
Lukrative Regionen für den Markt für ferngesteuerte Herzüberwachung
Markteinblicke
Zunahme bei der Inzidenz von Herz-Kreislauf-Erkrankungen
Die Patientenfernüberwachung (Remote Patient Monitoring, RPM) ermöglicht es Patienten, ihre Gesundheit besser zu verwalten, indem sie sich stärker an der Gesundheitsfürsorge beteiligen. Die American Heart Association unterstützt Initiativen, um Anreize für die Entwicklung und Nutzung evidenzbasierter Fernüberwachungstechnologien für Patienten zu schaffen. Nach Angaben der Weltgesundheitsorganisation (WHO) gehören Herz-Kreislauf-Erkrankungen weltweit zu den häufigsten Todesursachen und jedes Jahr erleiden etwa 30 Millionen Menschen einen Schlaganfall. Nach Angaben der American Heart Association leidet fast die Hälfte aller Erwachsenen in den USA an einer Form von Herz-Kreislauf-Erkrankung. Darüber hinaus werden bis 2035 voraussichtlich mehr als 130 Millionen Menschen, also 45,1 % der US-Bevölkerung, an einer Form von Herz-Kreislauf-Erkrankungen leiden. Berichten der Europäischen Gesellschaft für Kardiologie zufolge verursachen Herz-Kreislauf-Erkrankungen in Europa 3,9 Millionen Todesfälle und über 1,8 Millionen Todesfälle in der Europäischen Union (EU). Darüber hinaus sind sie für 45 % aller Todesfälle in Europa und 37 % aller Todesfälle in der EU verantwortlich. Die durch Herz-Kreislauf-Erkrankungen verursachten Todesfälle reichen in den asiatisch-pazifischen Ländern von weniger als 20 % in Ländern wie Thailand, den Philippinen und Indonesien bis zu 2030 % im städtischen China, Hongkong, Japan, Korea und Malaysia. Darüber hinaus weisen unter anderem Neuseeland, Australien und Singapur relativ hohe Raten von 3035 % auf.
Bluthochdruck ist ein wesentlicher Risikofaktor für Herz-Kreislauf-Erkrankungen. Die altersbereinigte Prävalenz von Bluthochdruck bei Erwachsenen in den USA beträgt etwa 35 %, was einer Bevölkerung von etwa 85 Millionen entspricht. Bis 2035 würden etwa 42 % der Erwachsenen im Land, also weitere 27 Millionen, an dieser Krankheit leiden. Auch die Kostenbelastung durch Bluthochdruck für die Volkswirtschaften steigt, und die Kosten dürften von etwa 70 Milliarden US-Dollar im Jahr 2015 auf etwa 150 Milliarden US-Dollar im Jahr 2035 steigen die wirtschaftliche Belastung, die sich aus längeren oder häufigen Krankenhausaufenthalten ergibt, die auf akute Ereignisse im Zusammenhang mit Bluthochdruck zurückzuführen sind. Untersuchungen haben gezeigt, dass RPM (Fernüberwachung des Patienten) den systolischen Blutdruck (SBP) und den diastolischen Blutdruck (DBP) im Vergleich zur üblichen Pflege und Selbstüberwachung allein deutlich senken kann. Einigen nicht-randomisierten Studien zufolge können RPM-Geräte die Ergebnisse verbessern, indem sie eine genaue und frühe Erkennung ermöglichen sowie die Gesamtmortalitätsraten und Krankenhausaufenthalte senken. Aktuelle klinische Leitlinien empfehlen dringend die Verwendung von RPM zur Erkennung von Vorhofflimmern (AF) sowohl bei Schlaganfall- als auch bei Nicht-Schlaganfall-Patienten.
Produkttypbasierte Erkenntnisse
Basierend auf dem Produkttyp, dem Der Markt für die Fernüberwachung des Herzens ist weiter in Geräte, Software und Dienstleistungen unterteilt. Das Gerätesegment hatte im Jahr 2021 einen größeren Marktanteil und wird im Prognosezeitraum voraussichtlich eine höhere CAGR verzeichnen.
Markt für ferngesteuerte Herzüberwachung nach Produkttyp 2021 und 2028
Endbenutzerbasierte Erkenntnisse
Basierend auf Endbenutzer, Der Markt für die Fernüberwachung des Herzens ist in Krankenhäuser und Kliniken, Notfalleinrichtungen, häusliche Pflegeeinrichtungen und andere unterteilt. Das Segment Krankenhäuser und Kliniken würde im Jahr 2021 den größten Marktanteil halten, während der Markt für das Notfallbereichssegment im Prognosezeitraum voraussichtlich mit einer jährlichen Wachstumsrate von 31,60 % wachsen wird.
Strategische Einblicke
Verschiedene Unternehmen, die auf dem Markt für die Fernüberwachung von Herzerkrankungen tätig sind, verfolgen Strategien wie Produkteinführungen, Fusionen und Übernahmen, Kooperationen, Produktinnovationen und Erweiterungen des Produktportfolios, um ihre Präsenz weltweit auszubauen, ihren Markennamen aufrechtzuerhalten und die wachsende Nachfrage von Endkunden zu befriedigen Benutzer.
Markt für ferngesteuerte Herzüberwachung nach Produkttyp
- Geräte
- Software
- Dienstleistungen
Markt für ferngesteuerte Herzüberwachung nach Endbenutzer
- Krankenhäuser und Kliniken
- Notfalleinstellungen
- Einstellungen für die häusliche Pflege
- Andere
Markt für ferngesteuerte Herzüberwachung nach Geografie
- Nordamerika
- USA
- Kanada
< li>Mexiko
- Frankreich
- Deutschland
- Italien
- Vereinigtes Königreich
- Spanien
- Restliches Europa
- China
< li>Indien
- Südafrika
- Saudi-Arabien
- VAE
- Übriger Naher Osten und Afrika< /li>
- Brasilien
- Argentinien
- Übriges Süd- und Mittelamerika< /li>
Unternehmensprofile
- OSI Systems, Inc.
- GE Healthcare
- Biotronik Se
- Nihon Kohden Corporation
- Abbott Laboratories
- Boston Scientific Corporation
- Koninklijke Philips NV
- Honeywell International, Inc.
- AMC Health
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Remote cardiac monitoring is the constant monitoring of electrical activities of the heart, which practices place outside hospitals. The monitoring can also be performed while the patient is doing the day-to-day activities. Devices like pacemakers and implantable cardioverter-defibrillator are placed with the patient through minimally invasive procedures. The transmission of data takes place within a transmitter that works in sync with the device. Remote cardiac monitoring technologies allow home electrocardiographic (ECG) monitoring of patients with suspected cardiac arrhythmias or at risk for developing arrhythmias. One of the most important benefits of remote cardiac device monitoring is that it cuts down on routine doctor visits. Without remote monitoring, patients visited the doctor every three to six months (depending on device type) for a data download. With remote monitoring, the number of visits have dropped to one to two per year. Remote cardiac device monitoring is a fantastic way to follow patients and it has always been important, but it’s especially important in this era of COVID-19.
Key factors that are driving the growth of this market are increase in incidence of cardiovascular diseases, continuous developments in telemedicine approach, and rising investment in research and development are expected to boost the market growth for the remote cardiac monitoring over the years.
The device segment dominated the global remote cardiac monitoring market and held the largest revenue share of 58.53% in 2021.
The hospitals and clinics segment dominated the global remote cardiac monitoring market and accounted for the largest revenue share of 37.60% in 2021.
The remote cardiac monitoring market majorly consists of the players such OSI Systems, Inc., GE Healthcare, Biotronik Se, Nihon Kohden Corporation, Abbott Laboratories, Boston Scientific Corporation, Koninklijke Philips N.V., Honeywell International, Inc. and AMC Health among others.
Global remote cardiac monitoring market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for remote cardiac monitoring. The US is estimated to hold the largest share in the remote cardiac monitoring market during the forecast period. The growth of the market can be because of the rising investments in cardiology informatics, connected devices, and mobile solutions for advanced cardiac care, increasing product launches, and R&D activities to develop advanced remote cardiac monitoring devices. In addition, technologically advanced products are likely to stimulate the growth of remote cardiac monitoring market in North America. On the other hand, growing emphasis on cost optimization, focus on streamlining of clinical processes, increasing number of clinical trials, rise in the government initiatives, growing number of research and development activities, and rising number of product launches and approvals in the Asia Pacific is expected to account for the fastest growth of the region during the coming years.
The List of Companies - Remote Cardiac Monitoring Market
- OSI Systems, Inc.
- GE Healthcare
- Biotronik Se
- Nihon Kohden Corporation
- Abbott Laboratories
- Boston Scientific Corporation
- Koninklijke Philips N.V.
- Honeywell International, Inc.
- AMC Health
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Sep 2021
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Sep 2021
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2021
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2021
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2021
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2021
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2021
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Sep 2021
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)